Foundation and RARE-X Release White Paper on Using Patient Owned Data

March 30, 2021

This paper explores the primary issues and requirements for data gathering that cell and gene therapy developers face. It also considers solutions, and the role a standardized non-proprietary data collection platform, such as RARE-X, can play in addressing these challenges.